![Weekly Enforcement Report: Big Settlements but Lab Cases Scarce](https://www.g2intelligence.com/wp-content/uploads/2023/06/June7-2023.News_.WeeklyEnforcementReport.UDTs-Settlements-iStock-844400552_1100x800-1080x675.jpg)
Weekly Enforcement Report: Big Settlements but Lab Cases Scarce
While the last few weeks haven’t seen many lab-related enforcement actions, several healthcare companies had to pay big.
While the last few weeks haven’t seen many lab-related enforcement actions, several healthcare companies had to pay big.
In recent key cases, the national drug retailer must stand trial for failing to protect customers from faulty Theranos products.
A recent False Claims Act settlement from Kentucky represents an unusual variation on a common theme.
Last week’s three key cases included two involving drug testing that was either medically unnecessary, or not provided at all.
In addition to the usual FCA-related fare, an arrest warrant was issued for a convicted lab co-owner after he failed to show up for prison.